Cargando…
Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation
New therapies to treat pancreatic cancer are direly needed. However, efficacious interventions lack a strong preclinical model that can recapitulate patients’ anatomy and physiology. Likewise, the availability of human primary malignant tissue for ex vivo studies is limited. These are significant li...
Autores principales: | Hendricks-Wenger, Alissa, Aycock, Kenneth N., Nagai-Singer, Margaret A., Coutermarsh-Ott, Sheryl, Lorenzo, Melvin F., Gannon, Jessica, Uh, Kyungjun, Farrell, Kayla, Beitel-White, Natalie, Brock, Rebecca M., Simon, Alexander, Morrison, Holly A., Tuohy, Joanne, Clark-Deener, Sherrie, Vlaisavljevich, Eli, Davalos, Rafael V., Lee, Kiho, Allen, Irving C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027815/ https://www.ncbi.nlm.nih.gov/pubmed/33828203 http://dx.doi.org/10.1038/s41598-021-87228-5 |
Ejemplares similares
-
Successful In Situ Targeting of Pancreatic Tumors in a Novel Orthotopic Porcine Model Using Histotripsy
por: Imran, Khan Mohammad, et al.
Publicado: (2023) -
Histotripsy Ablation Alters the Tumor Microenvironment and Promotes Immune System Activation in a Subcutaneous Model of Pancreatic Cancer
por: Hendricks-Wenger, Alissa, et al.
Publicado: (2021) -
Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for ex vivo Irreversible Electroporation Testing
por: Brock, Rebecca M., et al.
Publicado: (2020) -
Irreversible Electroporation: Background, Theory, and Review of Recent Developments in Clinical Oncology
por: Aycock, Kenneth N., et al.
Publicado: (2019) -
Frequency of off-targeting in genome edited pigs produced via direct injection of the CRISPR/Cas9 system into developing embryos
por: Carey, Kayla, et al.
Publicado: (2019)